NCT07718334 Impact of a Mobile Application-Based Medication Reminder on Treatment Adherence Among Patients With Chronic Diseases and Memory Impairment: A Nursing Leadership Perspective
| NCT ID | NCT07718334 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Mansoura University |
| Condition | Chronic Disease |
| Study Type | INTERVENTIONAL |
| Enrollment | 193 participants |
| Start Date | 2026-05-10 |
| Primary Completion | 2026-09 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 193 participants in total. It began in 2026-05-10 with a primary completion date of 2026-09.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to evaluate the impact of using a mobile application-based medication reminder on medication adherence among patients diagnosed with chronic diseases and memory impairment. Adherence to prescribed therapy is a significant challenge for this patient population, often leading to poor health outcomes and increased healthcare costs. From a nursing leadership perspective, innovative digital solutions can play a crucial role in supporting patient self-management. Using a quasi-experimental design, the study will investigate whether a customized mobile reminder system can effectively improve adherence rates and support patients in managing their therapeutic regimens.
Eligibility Criteria
Inclusion Criteria: * Patients diagnosed with one or more chronic diseases requiring regular long-term medication. * Patients exhibiting mild-to-moderate memory impairment or cognitive decline as screened by the Mini-Mental State Examination (MMSE). * Patients who personally own and are capable of operating a smartphone or have a primary caregiver willing to manage the mobile application. * Patients aged 18 years and older. * Patients who provide voluntary informed consent to participate in the study. Exclusion Criteria: * Patients with severe cognitive impairment or advanced dementia who cannot interact with mobile technology even with caregiver assistance. * Patients with severe acute clinical complications or unstable psychiatric conditions. * Patients participating in another concurrent clinical trial or study targeting medication adherence
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07718334 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Chronic Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07718334 currently recruiting?
Yes, NCT07718334 is actively recruiting participants. Contact the research team at asmaaelwan@mans.edu.eg for enrollment information.
Where is the NCT07718334 trial being conducted?
This trial is being conducted at Gamasa, Egypt, Kafr ash Shaykh, Egypt.
Who is sponsoring the NCT07718334 clinical trial?
NCT07718334 is sponsored by Mansoura University. The trial plans to enroll 193 participants.